1353049-83-8

Basic information

• Product Name: allyl 2-((6R,8R)-8-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2,4,4-tetraisopropyl-1,3,5,2,4-trioxadisilocan-6-yl)acetate
• Synonyms: allyl 2-((6R,8R)-8-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2,4,4-tetraisopropyl-1,3,5,2,4-trioxadisilocan-6-yl)acetate
• CAS NO: 1353049-83-8
• Molecular Weight: 841.223
• Mol File: 1353049-83-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: allyl 2-((6R,8R)-8-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2,4,4-tetraisopropyl-1,3,5,2,4-trioxadisilocan-6-yl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: allyl 2-((6R,8R)-8-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2,4,4-tetraisopropyl-1,3,5,2,4-trioxadisilocan-6-yl)acetate(1353049-83-8)
• EPA Substance Registry System: allyl 2-((6R,8R)-8-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2,4,4-tetraisopropyl-1,3,5,2,4-trioxadisilocan-6-yl)acetate(1353049-83-8)

Safety Data

• Hazardous Substances Data: 1353049-83-8(Hazardous Substances Data)

Upstream product

• 69304-37-6 1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane 
• 915092-85-2 allyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 134523-03-8 lipitor 

Downstream Products

• 1353050-28-8 (3R,5R)-((R)-3,4-bis (nitrooxy)butyl)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353050-07-3 C₄₉H₆₇FN₄O₁₂Si₂ 
• 1353050-29-9 (3R,5R)-((R)-2,3-bis(nitrooxy)propyl) 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353050-06-2 C₄₈H₆₅FN₄O₁₂Si₂ 
• 1353050-19-7 (3R,5R)-((S)-3,4-bis (nitrooxy)butyl) 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353050-04-0 C₄₉H₆₇FN₄O₁₂Si₂ 
• 1353050-30-2 (3R,5R)-((R)-2,6-bis(nitrooxy)hexyl) 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353050-02-8 C₅₁H₇₁FN₄O₁₂Si₂ 
• 1353050-21-1 (3R,5R)-((S)-2,6-bis(nitrooxy)hexyl) 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353050-00-6 C₅₁H₇₁FN₄O₁₂Si₂ 
• 1353050-22-2 (3R,5R)-((S)-2-(nitrooxy)-3-(3-(nitrooxy)propoxy)propyl)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353049-98-5 C₅₁H₇₁FN₄O₁₃Si₂ 
• 1353050-23-3 (3R,5R)-((S)-1-((R)-2,3-bis(nitrooxy)propyl)pyrrolidin-2-yl)methyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate 
• 1353049-96-3 C₅₃H₇₄FN₅O₁₂Si₂ 

Relevant articles and documents

STATIN DERIVATIVES

Dinitrate statins having improved pharmacological activity are described. They can be employed for treating and/or preventing several diseases, in particular acute coronary syndromes, neurodegenerative disorders as well as for reducing cholesterol levels.